Enjoy complimentary customisation on priority with our Enterprise License!
The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market size is estimated to grow by by USD 682.12 million between 2022 and 2027 accelerating at a CAGR of 12.13% .
The market's expansion relies on various elements, such as the escalating prevalence of staphylococcal infections, the implementation of novel MRSA diagnostic tests, and the enhanced integration of automation and systems in the healthcare sector. While the market demonstrates growth, it also faces obstacles like a scarcity of skilled practitioners. However, certain market trends like the increasing utilization of MRSA quick tests employing lab-on-chip technology and the emergence of PCR-free electrochemical point-of-care (POC) testing for swift clinical detection of MRSA will stimulate market growth.
This MRSA testing market report extensively covers market segmentation by end-user (hospitals and diagnostic laboratories and academic and research institutes), type (molecular diagnostics and immunodiagnostics), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download MRSA Testing Request Market Research Report Sample PDF
The increasing incidence of staphylococcal infections is notably driving the market growth, although factors such as the shortage of trained professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence of staphylococcal infections is a key factor driving the growth of the global methicillin-resistant staphylococcus aureus (MRSA) testing market. The emergence of antibiotic-resistant staphylococcal strains, such as MRSA and VRSA, has led to an increased incidence of staphylococcal infections. Most staphylococcal infections are known to develop in hospitals and other healthcare settings, such as dialysis centers and nursing homes. Prolonged hospitalization and increased exposure to open body surfaces due to the use of invasive clinical procedures have led to a rise in staphylococcal infections in healthcare settings.
Moreover, skin and soft tissue infections are the most common type of infections caused by Staphylococcus. The increasing incidence of antimicrobial drug failure in outpatient treatment has led to a rise in the number of skin and soft tissue infections. Thus, the rising incidence of staphylococcal infections is a major driver contributing to market growth during the forecast period.
The rise in the use of MRSA quick tests using lab-on-chip technology in hospital settings is the primary trend in the global methicillin-resistant staphylococcus aureus (MRSA) testing market growth. Those admitted into hospitals are tested for MRSA bacteria, whereas conventional laboratory sample testing takes more time to provide results. The lab-on-chip (LoC) is a small microfluidic component through which MRSA can be detected in one hour. This device identifies the presence of the MRSA virus in nasal swabs at the time of admission into hospitals. The sample is directly inserted into the LoC and placed in the analysis system. The main advantage of the LoC testing method is that the isolation and treatment of the patient can be initiated immediately if tested positive.
Moreover, LoC has multiple functions like storage, transport, mixing, separation, and detection of biological substances. The compact size and affordability have ensured considerable market growth. The recent device being tested for application in MRSA testing is Bactoquick from Germany-based DNE. This is a potential trend for the market in focus, which may drive its growth during the forecast period.
A shortage of trained professionals is a major challenge to the growth of the global methicillin-resistant staphylococcus aureus (MRSA) testing market. Processes involved in MRSA testing require the accurate interpretation of results, and researchers must be aware of what analysis to carry out and how to correlate it with the overall objective of the experiment. Hence, for successful research experiments, the researcher needs to have proper knowledge of the science involved. Therefore, the process of the detection of MRSA must be performed by highly skilled personnel.
The adoption of critical experiments is relatively new in the developing countries of APAC, Africa, and South America. Most laboratory technicians have not trained adequately on the latest technology in laboratory equipment and its benefits. Moreover, there is a shortage of trained professionals who can handle technologically advanced diagnostic devices. The lack of expertise increases the probability of a wrong diagnosis. Hence, the shortage of trained professionals will affect the growth of the market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global MRSA Testing Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Arlingtonscientific- The company offers MRSA testing such as Color Staph. Also, under this segment, the company focuses on the development, manufacturing, and sales of in-vitro diagnostics, diagnostic analyzers for syphilis screening, face shields, medical donor lounges for Apheresis and Blood Donor Collection, and nasal curettes for rapid viral testing.
The MRSA testing market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the hospital and diagnostic laboratories segment will be significant during the forecast period. Hospitals and diagnostic laboratories are an integral part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. Diagnostic techniques enable prompt and early intervention, thereby reducing disease burden and promoting health. The data obtained from patient samples are used for determining the medication required for MRSA.
Get a glance at the market contribution of various segments Request Market Research Report Sample PDF
The hospital and diagnostic laboratories segment was valued at USD 371.66 million in 2017 and continue to grow by 2021. Hospital-based reference laboratories collaborate only with hospitals for MRSA testing. Hospitals refer only a few complicated tests to these laboratories because of the large volume of patients in hospitals, long turnaround times, and high costs. These laboratories manage the high-test volume with advanced instruments and trained laboratory technicians. Similarly, Clinical-based reference laboratories are privately held reference laboratories that offer diagnostic and testing services for clinics. These reference laboratories are small and usually get references from small clinics, offices of healthcare professionals, and nursing homes. They do not have advanced and expensive equipment for rare and critical diagnoses, and hence they outsource the tests or diagnostics process to reference laboratories. Moreover, In some regions like China, India, and Brazil, the number of small clinics is increasing to meet the growing patient demand, which is expected to drive the growth of the methicillin-resistant staphylococcus aureus testing market in focus during the forecast period.
For more insights on the market share of various regions Request Market Research Report Sample PDF
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The methicillin-resistant staphylococcus aureus testing market in North America is witnessing significant growth, primarily because of the increasing demand for diagnostics such as HA-MRSA and CA-MRSA across different countries in North America. This has been brought about by the increased awareness among people to get diagnosed with MRSA infections. Most individuals in developed countries like US and Canada are opting for these tests, which has increased the sales of MRSA testing products in the market.
The outbreak of COVID-19 resulted in the shutdown of several manufacturing facilities in the US. However, the COVID-19 outbreak had a positive impact on the growth of the regional MRSA testing market during 2023-2027, owing to the increased need for hygiene control for people with COVID-19 in 2020. The outbreak prompted vendors of MRSA testing to increase production to meet the growing demand. This is coupled with the fact that North America is one of the fastest-growing regions in the market in focus. The regional market is expected to witness a growth rate of 11.29% in 2023 and 11.49% in 2024. Such factors are anticipated to propel the growth of the regional market during the forecast period.
The MRSA testing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
MRSA Testing Market Scope |
|
Report Coverage |
Details |
Page number |
162 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.13% |
Market growth 2023-2027 |
USD 682.12 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
11.45 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, Canada, Germany, UK, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample PDF
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.